Trexquant Investment LP - KARYOPHARM THERAPEUTICS INC ownership

KARYOPHARM THERAPEUTICS INC's ticker is KPTI and the CUSIP is 48576U106. A total of 141 filers reported holding KARYOPHARM THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 0.42 and the average weighting 0.1%.

Quarter-by-quarter ownership
Trexquant Investment LP ownership history of KARYOPHARM THERAPEUTICS INC
ValueSharesWeighting
Q3 2022$653,000
+50.5%
119,526
+24.3%
0.02%
+21.1%
Q2 2022$434,000
+101.9%
96,131
+230.3%
0.02%
+90.0%
Q1 2022$215,000
-84.9%
29,108
-86.8%
0.01%
-88.6%
Q4 2021$1,420,000
+573.0%
220,875
+510.1%
0.09%
+417.6%
Q3 2021$211,000
-16.6%
36,201
+47.5%
0.02%
-19.0%
Q2 2021$253,000
-29.5%
24,542
-28.1%
0.02%
-36.4%
Q1 2021$359,000
-36.2%
34,151
-6.2%
0.03%
-45.0%
Q4 2020$563,000
-30.3%
36,400
-14.6%
0.06%
+7.1%
Q2 2020$808,000
+700.0%
42,639
+152.2%
0.06%
+522.2%
Q2 2019$101,000
-30.8%
16,907
-32.3%
0.01%
-10.0%
Q1 2019$146,000
-27.0%
24,987
+112.8%
0.01%
-28.6%
Q2 2018$200,000
-51.9%
11,743
-62.1%
0.01%
-51.7%
Q1 2018$416,000
+105.9%
31,017
+38.8%
0.03%
-47.3%
Q2 2017$202,000
-26.0%
22,348
-23.0%
0.06%
+27.9%
Q4 2016$273,000
-48.4%
29,007
-27.3%
0.04%
-8.5%
Q4 2015$529,00039,9000.05%
Other shareholders
KARYOPHARM THERAPEUTICS INC shareholders Q1 2022
NameSharesValueWeighting ↓
Consonance Capital Management LP 4,767,078$80,993,0005.22%
Palo Alto Investors LP 4,663,324$79,230,0003.17%
DOHENY ASSET MANAGEMENT /CA 282,945$4,807,0002.61%
Private Capital Advisors, Inc. 416,900$7,083,0002.22%
Sandia Holdings, LLC 119,739$2,034,0000.91%
Virtus ETF Advisers LLC 44,986$764,0000.68%
Birchview Capital, LP 50,000$850,0000.58%
Schonfeld Strategic Advisors LLC 415,600$7,061,0000.38%
EMERALD ADVISERS, LLC 561,317$9,537,0000.36%
Kazazian Asset Management, LLC 20,672$351,0000.32%
View complete list of KARYOPHARM THERAPEUTICS INC shareholders